Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: The involvement of the neuroprotective factor DHCR24 (Seladin-1)

Journal of Endocrinology

Volumn 198, Issue 3, 2008, Pages 523-532

  Giannini, S ^a   Benvenuti, S ^a   Luciani, P ^a   Manuelli, C ^a   Cellai, I ^a   Deledda, C ^a   Pezzatini, A ^a   Vannelli, G B ^a   Maneschi, E ^a   Rotella, C M ^a   Serio, M ^a   Peri, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; ESTRADIOL; GLUCOSE; SELECTIVE ALZHEIMER DISEASE INDICATOR 1 PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC NEUROPATHY; FETUS; HUMAN; HUMAN CELL; NEUROBLAST; NEUROEPITHELIUM; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION;

CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR I; NERVE TISSUE PROTEINS; NEUROEPITHELIAL CELLS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 53349099394     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0613     Document Type: Article

References (52)

1. Armstrong CS, Wuarin L & Ishii DN 2000 Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. Journal of Neuroscience Research 59 649-660.
2. Babajko S, Leneuve P, Loret C & Binoux M 1997 IGF-binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells: its production is both IGF- and cell density-dependent. Journal of Endocrinology 152 221-227.
3. Bach LA & Rechler MM 1994 Insulin-like growth factors and diabetes. Diabetes/Metabolism Reviews 3 228-257.
4. Benvenuti S, Luciani P, Vannelli GB, Gelmini S, Franceschi E, Serio M & Peri A 2005 Estrogen and selective estrogen receptor modulators exerts neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. Journal of Clinical Endocrinology and Metabolism 90 1775-1782.
5. Brooker GJ, Kalloniatis M, Russo VC, Murphy M, Werther GA & Bartlett PF 2000 Endogenous IGF-I regulates the neuronal differentiation of adult stem cells. Journal of Neuroscience Research 59 332-341.
6. Busiguina S, Chowen JA, Argente J & Torres-Aleman I 1996 Specific alterations of the insulin-like growth factor I system in the cerebellum of diabetic rats. Endocrinology 137 4980-4987.
7. Ceriello A 1998 The emerging role of post-prandial hyperglycemic spikes in the pathogenesis of diabetic complications. Diabetic Medicine 15 188-193.
8. Chernausek SD, Murray MA & Cheung PT 1993 Expression of insulin-like growth factor binding protem-4 (IGFBP-4) by rat neural cells-comparison to other IGFBPs. Regulatory Peptides 48 123-132.
9. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, Lee HS, Tyner AL & Park JK 2003 Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. American Journal of Physiology 284 G996-G1005.
10. Daughaday WH, Mariz IK & Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radicirrummoassay of somatomedin in nativ and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism 51 781-788.
11. D'Ercole AJ, Ye P, Calikoglu AS & Gutierrez-Ospina G 1996 The role of the insulin-like growth factors in the central nervous system. Molecular Neurobiology 13 227-255.
12. Gammeltoft S, Haselbacher GK, Humbel RE, Fehlman M & Van Obberghen E 1985 Two types of receptors for insulin-like growth factors in mammalian brain. EMBO Journal 4 3407-3412.
13. Giannini S, Mohan S, Galli G, Rotella CM, LeBon TR & Fujita-Yamaguchi Y 1994 Characterization of insulin-like growth factor binding proteins (IGFBPs) produced by cultured fibroblasts from patients with NIDDM, IDDM and obesity. Journal of Clinical Endocrinology and Metabolism 79 1824-1830.
14. Giannini S, Cresci B, Pala L, Ciucci A, Manuelli C, Fujita-Yamaguchi Y, Cappugi P & Rotella CM 1999 Human glomerular endothelial cells IGFBPs are regulated by IGF-I and TGFβ1. Molecular and Cellular Endocrinology 154 123-136.
15. Giannini S, Cresci B, Pala L, Ciucci A, Franchini A, Manuelli C, Fujita-Yamaguchi Y, Cappugi P, Zonefrati R & Rotella CM 2001 IGFBPs modulate IGF-I, and high glucose-controlled growth of human retinal endothelial cells. Journal of Endocrinology 171 273-284.
16. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B & Nitsch RM 2001 The human DIMINUTO/DWARF1 homolog selachn-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. Journal of Neuroscience 20 7345-7352.
17. Gustafsson H, Soderdahl T, Jonsson G, Bratteng JO & Forsby A 2004 Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress. Journal of Neuroscience Research 77 285-291.
18. Han VK, Matsell DG, Delhanty PJ, Hill DJ, Shimasaki S & Nygard K 1996 IGF-binding proteins mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Hormone Research 45 160-166.
19. Ho EC, Lam KS, Chen YS, Yip JC, Arvindakshan M, Yamagishi S, Yagihashi S, Oates PJ, Ellery CA, Chung SS et al. 2006 Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55 1946-1953.
20. Hossenlop P, Seurin D, Segovia-Quinson B, Hardouin S & Binoux M 1986 Analysis of serum insulin-like growth factor binding protein using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Analytical Biochemistry 154 138-143.
21. Jover-Mengual T, Zukin RS & Etgen AM 2007 MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 148 1131-1143.
22. Kim EJ, Holthuizen PE, Kim J & Park JH 2005 Overexpression of mature insulin-like growth factor (IGF)-II leads to growth arrest in Caco-2 human colon cancer cells. Growth Hormone and IGF Research 15 64-71.
23. Kummer JL, Zawada WM, Freed CR, Chernausek SD & Heidenreich KA 1996 Insulin-like growth factor binding proteins in fetal rat mesencefalic cultures: regulation by fibroblast growth factor and insulin-like growth factor I. Endocrinology 137 3551-3556.
24. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V et al. 2008 TLR3 and TLR4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26 278-289.
25. Luciani P, Ferruzzi P, Arnaldi G, Crescioli C, Benvenuti S, Valeri A, Greeve I, Serio M, Mannelli M & Peri A 2004 Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. Journal of Clinical Endocrinology and Metabolism 89 1332-1339.
26. Luciani P, Deledda C, Rosati F, Benvenuti S, Cellai I, Dichiara F, Morello M, Vannelli GB, Danza G, Serio M et al. 2008 Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology (DOI. 10.1210/en.2007.1795).
27. Maggi M, Barni T, Fantoni G, Mancina R, Pupilli C, Luconi M, Crescioli C, Serio M & Vannelli GB 2000 Expression of biological effects endothelin-1 in human gonadotropin-releasing hormone- secreting neurons. Journal of Clinical Endocrinology and Metabolism 85 1685-1665.
28. Matthews CC & Feldman EL 1996 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. Journal of Cellular Physiology 166 323-331.
29. Matthews CC, Odeh HM & Feldman EL 1997 Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 79 525-534.
30. Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M & Monget P 2004 Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Hormone and IGF Research 14 71-84.
31. Mendez P, Azcoitia I & Garcia-Segura LM 2003 Estrogen receptor α forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Research. Molecular Brain Research 112 170-176.
32. Mendez P, Wandosell F & Garcia-Segura LM 2006 Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Frontiers in Neuroendocrinology 27 391-403.
33. Menouny M, Binoux M & Babajko S 1997 Role of insulin-like growth factor binding protein-2 and its proteolysis in neuroblastoma cell proliferation: modulation by transforming growth factor-β and retinoic acid. Endocrinology 138 683-690.
34. Mohan S & Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. Journal of Endocrinology 175 19-31.
35. Naeve GS, Vana AM, Eggold JR, Verge G, Ling N & Foster AC 2000 Expression of rat insulin-like growth binding protein-6 in the brain, spinal cord, and sensory ganglia. Brain Research. Molecular Brain Research 75 185-197.
36. Pal L, Chu H-P, Shu J, Topalli I, Santoro N & Karkanias G 2007 In vitro evidence of glucose-induced toxicity in GnRH secreting neurons: high glucose concentrations influence GnRH secretion, impair cell viability and induce apoptosis in the GT1-1 neuronal cell line. Fertility and Sterility 88 1143-1149.
37. Piconi L, Quagliaro L, Assaloni R, Da Ros R, Maier A, Zuodar G & Ceriello A 2006 Constant and intermittent high glucose enhances endothelial cells apoptosis through mitocondrial superoxide overproduction. Diabetes/Metabolism Research and Reviews 22 198-203.
38. Pons S & Torres-Aleman I 1992 Basic fibroblast factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology 131 2271-2278.
39. Roghani M, Hossenlop M, Lepade P, Balland A & Binoux M 1993 Isolation from human cerebrospinal fluid of a new insulin-like growth factor binding protein with a selective affinity for IGF-II. FEBS Letters 255 253-258.
40. Russo VC, Kobayashi K, Najdovska S, Baker NL & Werther GA 2004 Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system. Brain Research 1009 40-53.
41. Russo VC, Gluckman PD, Feldman EL & Werther GA 2005 The Insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews 26 916-943.
42. Sango K, Horie H, Saito H, Ajiki K, Tokashiki A, Takeshita K, Ishigatsubo Y, Kawano H & Ishikawa Y 2002 Diabetes is not a potent inducer of neuronal cell death in mouse sensory ganglia, but it enhances neurite regeneration in vitro. Life Sciences 71 2351-2368.
43. Sango K, Suzuki T, Yaganisawa H, Takaku S, Hirooka H, Tamura M & Watabe K 2006 High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. Journal of Neurochemistry 98 446-458.
44. The Diabetes Control and Complications Trial Research Group 1995 The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Medicine 122 561-568.
45. Tomlinson DR & Gardiner NJ 2008 Glucose neurotoxicity. Nature Reviews. Neuroscience 9 36-45.
46. Toth C, Brussee V, Cheng C & Zochodne DW 2004 Diabetes mellitus and sensory neuron. Journal of Neuropathology and Experimental Neurology 63 561-573.
47. Vannelli GB, Ensoli F, Zonefrati R, Kubota Y, Arcangeli A, Becchetti A, Camici G, Barni T, Thiele CJ & Balboni GC 1995 Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors. Journal of Neuroscience 15 4382-4394.
48. Vincent AM, Russell JW, Low P & Feldman EL 2004 Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 25 612-628.
49. Willaime-Morawek S, Arbez N, Mariani J & Brugg B 2005 IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2? Brain Research. Molecular Brain Research 142 97-106.
50. Yagihashi S, Kamijo M & Watanabe K 1990 Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically strptozotocin diabetic rats. American Journal of Pathology 136 1365-1373.
51. Zhou H, Hughes DE, Major ML, Yoo K, Pesold C & Costa RH 2001 Atypical mouse cerebellar development is caused by ectopic expression of the forkhead box transcription factor HNF-3β. Gene Expression 9 217-236.
52. Zhou R, Diehl D, Hoeflich A, Lahm H & Wolf E 2003 IGF-binding protein-4: biochemical characteristic and functional consequences. Journal of Endocrinology 178 177-193.